The Host-Encoded Heme Regulated Inhibitor (HRI) Facilitates Virulence-Associated Activities of Bacterial Pathogens

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Shrestha, Niraj ^a   Boucher, Justin ^a   Bahnan, Wael ^a   Clark, Emily S ^a   Rosqvist, Roland ^b   Fields, Kenneth A ^a   Khan, Wasif N ^a   Schesser, Kurt ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEME REGULATED INHIBITOR; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL INVASION; CHLAMYDIA; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFECTION RESISTANCE; LISTERIA; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; TYPE III SECRETION SYSTEM; YERSINIA;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; CELLS, CULTURED; CHLAMYDIA TRACHOMATIS; DISEASE RESISTANCE; EIF-2 KINASE; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; LISTERIA MONOCYTOGENES; MALE; MICE; VIRULENCE FACTORS; YERSINIA PSEUDOTUBERCULOSIS;

BACTERIA (MICROORGANISMS); CHLAMYDIA; LISTERIA; NEGIBACTERIA; POSIBACTERIA; YERSINIA;

EID: 84880031892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068754     Document Type: Article

References (30)

1. Kauppi AM, Nordfelth R, Uvell H, Wolf-Watz H, Elofsson M, (2003) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10: 241-249. doi:10.1016/S1074-5521(03)00046-2. PubMed: 12670538.
2. Keyser P, Elofsson M, Rosell S, Wolf-Watz H, (2008) Virulence blockers as alternatives to antibiotics: Type III secretion inhibitors against Gram-negative bacteria J Intern Med 264: 17-29. doi:10.1111/j.1365-2796.2008.01941.x. PubMed: 18393958.
3. Wiley DJ, Shrestha N, Yang J, Atis N, Dayton K, et al. (2009) The activities of the Yersinia protein kinase A YpkA) and outer protein J (YopJ) virulence factors converge on an eIF2alpha kinase. J Biol Chem 284: 24744-24753.
4. Shrestha N, Bahnan W, Wiley DJ, Barber G, Fields KA, et al. (2012) Eukaryotic initiation factor 2 (eIF2) signaling regulates proinflammatory cytokine expression and bacterial invasion J Biol Chem 287: 28738-28744. doi:10.1074/jbc.M112.375915. PubMed: 22761422.
5. Chen JJ, (2007) Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 109: 2693-2699. PubMed: 17110456.
6. Suragani RN, Zachariah RS, Velazquez JG, Liu S, Sun CW, et al. (2012) Heme-regulated eIF2α kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. Blood 119: 5276-5284.
7. Zhan K, Vattem KM, Bauer BN, Dever TE, Chen JJ, et al. (2002) Phosphorylation of eukaryotic initiation factor 2 by heme-regulated inhibitor kinase-related protein kinases in Schizosaccharomyces pombe is important for fesistance to environmental stresses. Mol Cell Biol 22: 7134-7146. doi:10.1128/MCB.22.20.7134-7146.2002. PubMed: 12242291.
8. McEwen E, Kedersha N, Song B, Scheuner D, Gilks N, et al. (2005) Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J Biol Chem 280: 16925-16933. doi:10.1074/jbc.M412882200. PubMed: 15684421.
9. Han AP, Yu C, Lu L, Fujiwara Y, Browne C, et al. (2001) Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J 20: 6909-6918.
10. Bölin I, Norlander L, Wolf-Watz H, (1982). Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect Immun 37: 506-512.
11. Håkansson S, Galyov EE, Rosqvist R, Wolf-Watz H, (1996) The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane Mol Microbiol 20: 593-603. doi:10.1046/j.1365-2958.1996.5251051.x. PubMed: 8736538.
12. Day JB, Ferracci F, Plano GV, (2003) Translocation of YopE and YopN into eukaryotic cells by Yersinia pestis yopN, tyeA, sycN, yscB and lcrG deletion mutants measured using a phosphorylatable peptide tag and phosphospecific antibodies. Mol Microbiol 47: 807-823. doi:10.1046/j.1365-2958.2003.03343.x. PubMed: 12535078.
13. Liu S, Suragani RN, Wang F, Han A, Zhao W, et al. (2007) The function of heme-regulated eIF2alpha kinase in murine iron homeostasis and macrophage maturation J Clin Invest 117: 3296-3305. doi:10.1172/JCI32084. PubMed: 17932563.
14. Viboud GI, Bliska JB, (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69-89. doi:10.1146/annurev.micro.59.030804.121320. PubMed: 15847602.
15. Rosqvist R, Forsberg A, Wolf-Watz H, (1991) Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun 59: 4562-4569. PubMed: 1937815.
16. Okan NA, Bliska JB, Karzai AW, (2006) A Role for the SmpB-SsrA system in Yersinia pseudotuberculosis pathogenesis. PLOS Pathog 2: e6. doi:10.1371/journal.ppat.0020006. PubMed: 16450010.
17. Håkansson S, Schesser K, Persson C, Galyov EE, Rosqvist R, et al. (1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity EMBO J 15: 5812-5823. PubMed: 8918459.
18. Mejía E, Bliska JB, Viboud GI, (2008) Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLOS Pathog 4: e3. doi:10.1371/journal.ppat.0040003. PubMed: 18193942.
19. Betts HJ, Wolf K, Fields KA, (2009) Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal. Curr Opin Microbiol 12: 81-87. doi:10.1016/j.mib.2008.11.009. PubMed: 19138553.
20. Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, et al. (2006) A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis Proc Natl Acad Sci U S A 103: 14566-14571. doi:10.1073/pnas.0606412103. PubMed: 16973741.
21. Wolf K, Betts HJ, Chellas-Géry B, Hower S, Linton CN, et al. (2006) Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 61: 1543-1555. doi:10.1111/j.1365-2958.2006.05347.x. PubMed: 16968227.
22. Muschiol S, Normark S, Henriques-Normark B, Subtil A, (2009) Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells. BMC Microbiol 9: e75. doi:10.1186/1471-2180-9-75. PubMed: 19383140.
23. Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER, (1999) The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1: 119-130. doi:10.1046/j.1462-5822.1999.00012.x. PubMed: 11207546.
24. Cossart P, (2011) Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes Proc Natl Acad Sci U S A 108: 19484-19491. doi:10.1073/pnas.1112371108. PubMed: 22114192.
25. Schnupf P, Portnoy DA, (2007) Listeriolysin O: A phagosome-specific lysin Microbes Infect 9: 1176-1187. doi:10.1016/j.micinf.2007.05.005. PubMed: 17720603.
26. Singh R, Jamieson A, Cresswell P, (2008) GILT is a critical host factor for Listeria monocytogenes infection. Nature 455: 1244-1247. doi:10.1038/nature07344. PubMed: 18815593.
27. Alexander JJ, (1968) Separation of protein synthesis in meningopneumonitisgent from that in L cells by differential susceptibility to cycloheximide. J Bacteriol 95: 327-332. PubMed: 5640375.
28. Rosen MD, Woods CR, Goldberg SD, Hack MD, Bounds AD, et al. (2009) Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2alpha (HRI) kinase Bioorg Med Chem Lett 19: 6548-6551. doi:10.1016/j.bmcl.2009.10.033. PubMed: 19854648.
29. Zhao H, Brandt GE, Galam L, Matts RL, Blagg BS, (2011) Identification and initial SAR of silybin: an Hsp90 inhibitor. Bioorg Med Chem Lett 21: 2659-2664. doi:10.1016/j.bmcl.2010.12.088. PubMed: 21273068.
30. Davenport J, Manjarrez JR, Peterson L, Krumm B, Blagg BS, et al. (2011) Gambogic acid, a natural product inhibitor of Hsp90. J Nat Prod 74: 1085-1092. doi:10.1021/np200029q. PubMed: 21486005.